InfuSystem Holdings, Inc. (INFU) - Pangali EV/EBITDA

This chart of the current share price of InfuSystem Holdings (INFU) on the GURU.Markets platform demonstrates an EV/EBITDA ratio of 11.62. The business generates revenue by providing services and leasing infusion pumps to oncology centers. The specific nature of the industry guarantees resilience to global crises, turning the asset into a defensive asset due to medical necessity. Personnel are attracted by the social mission and strong social guarantees.

This multiple compares the total enterprise value, including net debt, with its operating profit before taxes, depreciation, and amortization. The EV/EBITDA trend for a capital-intensive business allows for an assessment of the real value of assets relative to the generated cash flow. The metric is calculated by dividing the sum of market capitalization and liabilities by EBITDA. For InfuSystem Holdings (INFU), with its recurring contracts in the oncology pump sector, this indicator confirms fundamental stability and revenue predictability.